Draig Therapeutics

Draig Therapeutics company information, Employees & Contact Information

Draig Therapeutics is a clinical-stage company with a mission to transform treatments in Neuropsychiatry. The company is leveraging its founders’ unique scientific expertise in modulating the core glutamate / GABA pathways that play a critical role in neuropsychiatric diseases to advance a pipeline of groundbreaking therapies designed to address large unmet patient needs, including in Major Depressive Disorder (MDD). Draig is the Welsh word for ‘dragon’ and it reflects the company’s origins in Wales. The name and logo were inspired by this heritage, reflecting its scientific roots stemming from Cardiff University.
Looking for a particular Draig Therapeutics employee's phone or email?

Draig Therapeutics Questions

News

Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors - Yahoo Finance

Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors Yahoo Finance

Draig Therapeutics Launches with $140 Million (£107 - GlobeNewswire

Draig Therapeutics Launches with $140 Million (£107 GlobeNewswire

Draig Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of DT-101 for the Treatment of Major Depressive Disorder - The Manila Times

Draig Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of DT-101 for the Treatment of Major Depressive Disorder The Manila Times

Draig Therapeutics - The Pharma Letter

Draig Therapeutics The Pharma Letter

Neuropsychiatry biotech Draig Therapeutics hatches with red-hot $140M series A - Fierce Biotech

Neuropsychiatry biotech Draig Therapeutics hatches with red-hot $140M series A Fierce Biotech

Draig Therapeutics flies out of stealth to treat depression - Chemical & Engineering News

Draig Therapeutics flies out of stealth to treat depression Chemical & Engineering News

Draig Therapeutics Emerges With $140M for Clinical Tests of Novel Neuropsychiatric Drugs - MedCity News

Draig Therapeutics Emerges With $140M for Clinical Tests of Novel Neuropsychiatric Drugs MedCity News

$140 Million investment in new therapies for neuropsychiatric disorders - Cardiff University

$140 Million investment in new therapies for neuropsychiatric disorders Cardiff University

Draig Is All Fired Up To Transform Neuropsychiatric Field - Citeline News & Insights

Draig Is All Fired Up To Transform Neuropsychiatric Field Citeline News & Insights

Top Draig Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant